サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463588

アジア太平洋の牛の診断薬：2030年市場予測-地域別分析-製品、疾患タイプ、エンドユーザー別

Asia Pacific Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
出版日: | 発行: The Insight Partners | ページ情報: 英文 86 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アジア太平洋の牛の診断薬：2030年市場予測-地域別分析-製品、疾患タイプ、エンドユーザー別
出版日: 2024年01月19日
発行: The Insight Partners
ページ情報: 英文 86 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の牛の診断薬市場は、2022年の2億5,042万米ドルから2030年には4億8,294万米ドルに成長すると予測されています。2022～2030年のCAGRは8.6%と推定されます。

牛結核の高い有病率がアジア太平洋の牛の診断薬市場を後押し

牛結核（bTB）は、主に牛が罹患し、後に他の動物や人間に感染する慢性感染症です。世界動物保健機構（WOAH）は、bTBを可能な限り早期に発見し報告しなければならない病気の一つに挙げています。Thermo Fisher Scientific社が2023年5月に発表したデータによると、bTBは世界で5,000万頭以上の牛に感染し、年間30億米ドルの経済的損失をもたらしています。

bTBの流行は地域によって異なります。しかし、アジアの一部の地域では、bTBの有病率は50％を超えています。技術やインフラの開発が進んでいるにもかかわらず、多くの国々ではbTBを効果的に診断することができないです。これはbTBが複雑な病気であり、診断のための普遍的な戦略がないためです。このシナリオは、牛の診断薬市場の参入企業がアジアでの認知度を高め、これらの国々の社会経済状況に適した新製品を発売する機会を記載しています。

アジア太平洋の牛の診断薬市場概要

アジア太平洋の牛の診断薬市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。2023年にBMC Journalsに掲載された論文によると、bTBは中国の主要な風土病であり、乳牛生産に大きな損失をもたらしています。中国農業農村部は、動物疾病予防管理中長期国家計画（2012～2020年）において、乳牛のbTBを、畜産業に加えて人間の福祉にも影響を及ぼすことから、管理・排除すべき16の感染症の1つに分類しています。牛ブルセラ症、牛マイコプラズマ（M.bovis）病、パラツベルクリン症、牛白血病などの病気については、乳を使った試験が行われます。生乳サンプルの採取と試験は乳牛にあまり影響を与えないため、酪農労働者の協力も得られます。中国の国家酪農牛群改良（DHI）プログラムでも、泌乳牛から毎月乳サンプルを採取し、その後繁殖適性と乳質を評価するために乳サンプルを試験することを強調しています。また、乳房炎を早期発見するために、CombiFoss FT+乳成分分析装置と体細胞分析装置を用いて乳サンプルを評価することも推奨しています。中国は現在、国や地方レベル、そして農場でのサーベイランスプログラムに基づいて、試験と屠殺政策によるbTBコントロール戦略を実施しています。マイコバクテリウム・ボビスの培養は、bTBを診断するための「ゴールドスタンダード」です。しかし、培養によるM.bovisの同定は、感度が低く、面倒で時間がかかり、病原体の持続的感染、遅い増殖、潜在的に危険な特性のため、高レベルのバイオセーフティ実験施設が必要です。現在、中国ではツベルクリン皮膚テストがbTBを検出するために推奨され、農場で家畜に実施されている従来の試験です。このように、bTB疾病の増加と政府による診断支援が、中国における牛の診断薬市場の成長を後押ししています。

アジア太平洋の牛の診断薬市場の収益と2030年までの予測（金額）

アジア太平洋の牛の診断薬市場セグメンテーション

アジア太平洋の牛の診断薬市場は、製品タイプ、疾患タイプ、エンドユーザー、国別に区分されます。

製品別に見ると、アジア太平洋の牛の診断薬市場は、イムノアッセイキット、PCR試薬＆キット、赤血球凝集阻害（HI）アッセイ、その他の製品に区分されます。2022年のアジア太平洋の牛の診断薬市場では、イムノアッセイキット部門が最大のシェアを占めています。

疾病タイプ別に見ると、アジア太平洋の牛の診断薬市場は、牛ウイルス性下痢（BVD）、牛結核（TB）、牛乳房炎、口蹄疫（FMD）、その他の疾病タイプに区分されます。2022年のアジア太平洋の牛の診断薬市場では、牛乳房炎セグメントが最大のシェアを占めています。

エンドユーザー別に見ると、アジア太平洋の牛の診断薬市場は動物病院、動物クリニック、その他のエンドユーザーに区分されます。動物病院セグメントが2022年のアジア太平洋牛の診断薬市場で最大のシェアを占めています。

国別に見ると、アジア太平洋の牛の診断薬市場は中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。2022年のアジア太平洋牛の診断薬市場は中国が独占

bioMerieux SA、Bionote Inc、Idexx Laboratories Inc、Innovative Diagnostics SAS、Neogen Corp、Ring Biotechnology Co Ltd、Shenzhen Bioeasy Biotechnology Co Ltd、Thermo Fisher Scientific Incは、アジア太平洋の牛の診断薬市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の牛の診断薬市場-主要産業力学

  • 主要市場の促進要因
    • 牛乳房炎の高い流行率と経済的影響
    • 製品上市数の増加
  • 主要市場抑制要因
    • 獣医療研究における熟練専門家の不足
  • 主要市場機会
    • 牛結核の高い有病率
  • 今後の動向
    • データ分析と人工知能（AI）の統合
  • 影響分析

第5章 牛の診断薬市場：アジア太平洋市場分析

  • アジア太平洋の牛の診断薬市場収益、2022～2030年

第6章 アジア太平洋の牛の診断薬市場：2030年までの収益と予測：製品別

  • イントロダクション
  • アジア太平洋の牛の診断薬市場：2022年と2030年の製品別売上高シェア（%）
  • 免疫測定キット
  • PCRキット
  • 血球凝集阻害（HI）アッセイ
  • その他

第7章 アジア太平洋の牛の診断薬市場：2030年までの収益と予測：疾患タイプ別

  • イントロダクション
  • アジア太平洋の牛の診断薬市場：2022年と2030年の疾患タイプ別売上高シェア（%）
  • 牛ウイルス性下痢症（BVD）
  • 牛結核（TB）
  • 牛乳房炎
  • 口蹄疫（FMD）
  • その他の疾病タイプ

第8章 アジア太平洋の牛の診断薬市場：2030年までの収益と予測：エンドユーザー別

  • イントロダクション
  • アジア太平洋牛の診断薬市場：2022年と2030年のエンドユーザー別売上高シェア（%）
  • 動物病院
  • 動物クリニック
  • その他

第9章 アジア太平洋の牛の診断薬市場：国別分析

  • アジア太平洋の牛の診断薬市場：国別分析
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他のアジア太平洋

第10章 牛の診断薬市場：業界情勢

  • イントロダクション
  • 成長戦略
    • 概要

第11章 企業プロファイル

  • Idexx Laboratories Inc
  • Thermo Fisher Scientific Inc
  • Innovative Diagnostics SAS
  • Neogen Corp
  • bioMerieux SA
  • Ring Biotechnology Co Ltd
  • Bionote Inc
  • Shenzhen Bioeasy Biotechnology Co Ltd

第12章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Bovine Diagnostics Market Segmentation
  • Table 2. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 4. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 5. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 6. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 7. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 8. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 9. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 10. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 11. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 12. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 13. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 16. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 17. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 18. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Type
  • Table 19. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 20. Recent Growth Strategies in Asia Pacific Bovine Diagnostics Market
  • Table 21. Glossary of Terms, Asia Pacific Bovine Diagnostics Market

List Of Figures

  • Figure 1. Asia Pacific Bovine Diagnostics Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Market Attractiveness
  • Figure 4. Asia Pacific Bovine Diagnostics Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. Asia Pacific Bovine Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 7. Asia Pacific Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Immunoassay Kits: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. PCR Kits: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hemagglutination Inhibition (HI) Assay: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Other Products: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
  • Figure 13. Bovine Viral Diarrhea (BVD): Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Bovine Tuberculosis (TB): Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Bovine Mastitis: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Foot and Mouth Disease (FMD): Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Other Disease Types: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Asia Pacific Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
  • Figure 19. Veterinary Hospitals: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Veterinary Clinics: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Other End-Users: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific Bovine Diagnostics Market, By Country, 2022 ($Mn)
  • Figure 23. Asia Pacific Bovine Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 24. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029330

The Asia Pacific bovine diagnostics market is expected to grow from US$ 250.42 million in 2022 to US$ 482.94 million by 2030. It is estimated to grow at a CAGR of 8.6% from 2022 to 2030.

High Prevalence of Bovine Tuberculosis Fuels Asia Pacific Bovine Diagnostics Market

Bovine tuberculosis (bTB) is a chronic infectious disease that primarily affects cattle and is later transmitted to other animals and humans. The World Organization for Animal Health (WOAH) has listed bTB as one of the diseases that must be detected and reported as earliest as possible. As per the data shared by Thermo Fisher Scientific in May 2023, bTB affects more than 50 million cattle worldwide, incurring annual economic losses of ~US$ 3 billion.

The prevalence of bTB differs in different geographic areas. However, its prevalence reaches beyond bTB 50% in some parts of Asia. Despite the ongoing technological and infrastructural developments, many countries fail to effectively diagnose bTB due to the complexity of the disease and the lack of universal strategies for its diagnosis. This scenario provides opportunities for bovine diagnostics market players to enhance awareness in Asia and launch new products that suit the socioeconomic conditions in these countries.

Asia Pacific Bovine Diagnostics Market Overview

The Asia Pacific bovine diagnostics market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. According to an article published in BMC Journals in 2023, bTB is a major endemic in China that results in major losses in dairy cattle production. In its Medium and Long-Term National Plan for Prevention and Control of Animal Diseases (2012-2020), the Ministry of Agriculture and Rural Affairs in China has classified the bTB of dairy cattle as one of the 16 infectious diseases that should be controlled and eliminated, as the disease also affects human welfare in addition to the livestock industry. A milk-based test is performed for diseases such as bovine brucellosis, Mycoplasma bovis (M. bovis) disease, paratuberculosis, and bovine leukosis. The collection and testing of milk samples do not have much impact on dairy cows, which also results in greater cooperation from dairy workers. The National Dairy Herd Improvement (DHI) Program of China also emphasizes on the collection of milk samples from lactating cows monthly, followed by testing them to assess breeding suitability and milk quality. It also recommends evaluating the milk samples to detect mastitis in the early stages using a CombiFoss FT + milk composition and a somatic cell analyzer. China implements its current bTB control strategy through test-and-slaughter policies, which are based on surveillance programs at the national and local levels, as well as on farms. Mycobacterium bovis culture is the "gold standard" for diagnosing bTB. However, the identification of M. bovis by culturing it is insensitive, cumbersome, and time-consuming, and it requires high-level biosafety laboratory facilities because of the persistent infection, slow growth, and potentially dangerous characteristics of the pathogen. Currently, the tuberculin skin test is the recommended and conventional test performed on animals at farms in China for detecting bTB, while the blood interferon-gamma in vitro release test is an alternative laboratory diagnostic test available. Thus, increasing bTB disease and support by government for diagnosis boosts the growth of bovine diagnostics market growth in China.

Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Bovine Diagnostics Market Segmentation

The Asia Pacific bovine diagnostics market is segmented into product, disease type, end user, and country.

Based on product, the Asia Pacific bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.

Based on disease type, the Asia Pacific bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.

Based on end user, the Asia Pacific bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.

Based on country, the Asia Pacific bovine diagnostics market is segmented int o China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bovine diagnostics market in 2022.

bioMerieux SA, Bionote Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, Shenzhen Bioeasy Biotechnology Co Ltd, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bovine diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Bovine Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 High Prevalence and Economic Impact of Bovine Mastitis
    • 4.1.2 Increasing Number of Product Launches
  • 4.2 Key Market Restraints:
    • 4.2.1 Lack of Skilled Professionals in Veterinary Research
  • 4.3 Key Market Opportunities:
    • 4.3.1 High Prevalence of Bovine Tuberculosis
  • 4.4 Future Trends
    • 4.4.1 Integration of Data Analytics and Artificial Intelligence (AI)
  • 4.5 Impact Analysis:

5. Bovine Diagnostics Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Bovine Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Asia Pacific Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Immunoassay Kits
    • 6.3.1 Overview
    • 6.3.2 Immunoassay Kits: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 PCR Kits
    • 6.4.1 Overview
    • 6.4.2 PCR Kits: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Hemagglutination Inhibition (HI) Assay
    • 6.5.1 Overview
    • 6.5.2 Hemagglutination Inhibition (HI) Assay: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Other Products
    • 6.6.1 Overview
    • 6.6.2 Other Products: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 - by Disease Type

  • 7.1 Overview
  • 7.2 Asia Pacific Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
  • 7.3 Bovine Viral Diarrhea (BVD)
    • 7.3.1 Overview
    • 7.3.2 Bovine Viral Diarrhea (BVD): Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bovine Tuberculosis (TB)
    • 7.4.1 Overview
    • 7.4.2 Bovine Tuberculosis (TB): Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Bovine Mastitis
    • 7.5.1 Overview
    • 7.5.2 Bovine Mastitis: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Foot and Mouth Disease (FMD)
    • 7.6.1 Overview
    • 7.6.2 Foot and Mouth Disease (FMD): Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Disease Types
    • 7.7.1 Overview
    • 7.7.2 Other Disease Types: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Asia Pacific Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
  • 8.3 Veterinary Hospitals
    • 8.3.1 Overview
    • 8.3.2 Veterinary Hospitals: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Veterinary Clinics
    • 8.4.1 Overview
    • 8.4.2 Veterinary Clinics: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Other End-Users
    • 8.5.1 Overview
    • 8.5.2 Other End-Users: Asia Pacific Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Bovine Diagnostics Market - Country Analysis

      • 9.1.1.1 Asia Pacific Bovine Diagnostics Market, by Country
      • 9.1.1.2 China
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 China: Asia Pacific Bovine Diagnostics Market, by Product
        • 9.1.1.2.4 China: Asia Pacific Bovine Diagnostics Market, by Disease Type
        • 9.1.1.2.5 China: Asia Pacific Bovine Diagnostics Market, by End User
      • 9.1.1.3 Japan
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Japan: Asia Pacific Bovine Diagnostics Market, by Product
        • 9.1.1.3.4 Japan: Asia Pacific Bovine Diagnostics Market, by Disease Type
        • 9.1.1.3.5 Japan: Asia Pacific Bovine Diagnostics Market, by End User
      • 9.1.1.4 India
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 India: Asia Pacific Bovine Diagnostics Market, by Product
        • 9.1.1.4.4 India: Asia Pacific Bovine Diagnostics Market, by Disease Type
        • 9.1.1.4.5 India: Asia Pacific Bovine Diagnostics Market, by End User
      • 9.1.1.5 South Korea
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 South Korea: Asia Pacific Bovine Diagnostics Market, by Product
        • 9.1.1.5.4 South Korea: Asia Pacific Bovine Diagnostics Market, by Disease Type
        • 9.1.1.5.5 South Korea: Asia Pacific Bovine Diagnostics Market, by End User
      • 9.1.1.6 Australia
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 Australia: Asia Pacific Bovine Diagnostics Market, by Product
        • 9.1.1.6.4 Australia: Asia Pacific Bovine Diagnostics Market, by Disease Type
        • 9.1.1.6.5 Australia: Asia Pacific Bovine Diagnostics Market, by End User
      • 9.1.1.7 Rest of Asia Pacific
        • 9.1.1.7.1 Overview
        • 9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market, by Product
        • 9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market, by Disease Type
        • 9.1.1.7.5 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market, by End User

10. Bovine Diagnostics Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies
    • 10.2.1 Overview

11. Company Profiles

  • 11.1 Idexx Laboratories Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Thermo Fisher Scientific Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Innovative Diagnostics SAS
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Neogen Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 bioMerieux SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Ring Biotechnology Co Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Bionote Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Shenzhen Bioeasy Biotechnology Co Ltd
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms